New generation antipsychotic drugs and compliance behaviour

@article{Voruganti2008NewGA,
  title={New generation antipsychotic drugs and compliance behaviour},
  author={L. Voruganti and Laura K Baker and A. Awad},
  journal={Current Opinion in Psychiatry},
  year={2008},
  volume={21},
  pages={133–139}
}
Purpose of review Antipsychotic therapy has been eclipsed by high rates of noncompliance; the problem was attributed to a lack of efficacy and the burden of side effects of neuroleptics. This review sought to examine whether the arrival of second generation (atypical) antipsychotic drugs with low side-effect liability and improved efficacy has helped to positively reinforce compliance behaviour among people treated for schizophrenia. Recent findings The number of studies that systematically… Expand
Attitudes Towards Antipsychotics Among Patients with Schizophrenia on First- or Second-Generation Medications
A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders
Evaluation of treatment adherence in outpatients with schizophrenia
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 65 REFERENCES
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
...
1
2
3
4
5
...